ABBV-706

ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena
Mon, 06/3/24 - 12:06 pm
ASCO 2024
AbbVie
antibody-drug conjugates
Teliso-V
ABBV-400
ABBV-706
solid tumors